Home > Healthcare > Medical Devices > Diagnostic Devices > Preterm Birth Diagnostic Test Kits Market

Preterm Birth Diagnostic Test Kits Market Trends

Report ID: GMI4044
Published Date: May 2023
Report Format: PDF

Download Free Sample

Preterm Birth Diagnostic Test Kits Market Trends

The rising incidence of preterm births, as well as the improved survival rates of premature infants, has contributed to the need for more neonatal ICUs. Preterm infants often require specialized care due to their unique medical needs and higher vulnerability to complications. Technological advancements in medical equipment, monitoring systems, and treatment modalities have allowed for more complex and specialized care in paediatric and neonatal ICUs. These advancements have driven the establishment of new units to provide the necessary infrastructure and resources. Additionally, paediatric, and neonatal ICUs increasingly prioritize family-centered care, recognizing the importance of involving parents and caregivers in the care of their child. This approach supports parental involvement, communication, and emotional support, creating a more inclusive and supportive environment for families. Thus, such initiatives will lead to high product demand in the near future.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for preterm birth diagnostic test kits was valued at over USD 419 million in 2022 and is projected to reach more than USD 856 million by 2032, owing to high incidence of preterm births, along with increasing awareness about early detection of fetal anomalies.

Fetal fibronectin test kits (fFN) segment held the largest revenue size over USD 197 million in 2022 and will grow significantly through 2032, on account of high sensitivity of the test in detecting the presence of fetal fibronectin, a protein that acts as a biomarker for preterm birth.

U.S. market for preterm birth diagnostic test kits accounted for more than USD 158 million in 2022 and will gather more than USD 344 million by 2032. The affordability of preterm birth diagnostic test kits and ongoing technological developments are primarily responsible for the regional market growth.

Abbott, Creative Diagnostics, Clinical Innovations, Hologic, IQ Products, Qiagen, Medixbiochemica, Biosynex, CooperSurgical Inc, Sera Progonstics, and Stryker Corporation among others.